Advertisement
Research Article| Volume 22, ISSUE 5, P559-572, May 1987

Serial DST, TRH test, and TRH-like immunoreactivity measurements in major affective disorders

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Neuroendocrine functions in depressed patients with major affective disorders were serially investigated by the Dexamethasone Suppression Test (DST), the thyrotropin-releasing hormone (TRH) stimulation test, and the plasma TRH-like immunoreactivity (TRH-LI) measurement. Prior to antidepressant therapy, the sensitivity for nonsuppression to the DST was 36.0%, whereas that for blunted thyroid-stimulating hormone (TSH) response to TRH was 28.0%. Both DST nonsuppression and TSH blunting appeared to be state-related markers for depressed patients. Specifically, a significant increase of maximum TSH response to TRH after 4 weeks of antidepressant therapy was associated with clinical improvement. Plasma TRH-LI in depressed patients was significantly lower than that of healthy controls. It is possible that the lower plasma TRH-LI level is related to the pathophysiology of some depressed patients with major affective disorders.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aggernaes H
        • Kirkegaard C
        • Krog-Meyer I
        • Kijne B
        • Larsen JD
        • Laurse AL
        • Lykke-Olesen L
        • Mikkelsen PL
        • Rasmussen S
        • Bjørum N
        Dexamethasone Suppression Test and TRH test in endogenous depression.
        Acta Psychiatr Scand. 1983; 67: 258
        • Ågren H
        • Lundquist G
        Low level of somatostatin in human CSF mark depressive episodes.
        Psychoneuroendocrinology. 1984; 9: 233
        • Albala AA
        • Greden JF
        • Tarika J
        • Carroll BJ
        Changes in serial Dexamethasone Suppression Tests among unipolar depressives receiving electroconvulsive treatment.
        Biol Psychiatry. 1981; 16: 551
        • American Psychiatric Association
        3rd ed. Diagnostic and Statistical Manual of Mental Disorders. APA, Washington, DC1980
        • Åsberg M
        • Cronholm B
        • Sjöquist F
        Relationship between plasma level and therapeutic effect of nortriptyline.
        Br Med J. 1971; 3: 331
        • Åsberg M
        • Thoren P
        • Traskman L
        • Bertilsson L
        • Ringberger V
        Serotonin depression: A biochemical subgroup within the affective disorders?.
        Science. 1976; 191: 478
        • Bassiri RM
        • Utiger RD
        The preparation of specificity of antibody to thyrotropin releasing hormone.
        Endocrinology. 1972; 90: 722
        • Bassiri RM
        • Utiger RD
        Serum inactivation of the immunological and biological activity of thyrotropin-releasing hormone (TRH).
        Endocrinology. 1972; 91: 657
        • Bassiri RM
        • Utiger RD
        Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.
        J Clin Invest. 1973; 52: 1616
        • Beck AT
        • Ward CH
        • Mendelson M
        • Mock J
        • Erbaugh J
        An inventory for measuring depression.
        Arch Gen Psychiatry. 1961; 4: 53
        • Bertilsson L
        • Åsberg M
        • Thoren P
        Differential effect of clomipramine and nortriptyline or cerebrospinal fluid metabolites of serotonin and noradrenaline in depression.
        Eur J Clin Pharmacol. 1974; 7: 365
        • Bissette G
        • Walleus H
        • Widerlov E
        • Karlsson I
        • Eklundt K
        • Loosen PT
        • Nemeroff CB
        Reduction of CSF concentration of SRIF-LI in dementia, major depression, and schizophrenia.
        in: Annual Meeting of Society for Neuroscience, Anaheim, CA1984 (abstr).
        • Brown WA
        • Quails CB
        Pituitary-adrenal disinhibition in depression: Marker of a response to treatment?.
        Psychiatry Res. 1981; 4: 115
        • Brown WA
        • Johnston R
        • Manfield D
        The 24-hour Dexamethasone Suppression Test in a clinical setting: Relationship to diagnosis, symptoms, and response to treatment.
        Am J Psychiatry. 1979; 136: 543
        • Carroll BJ
        The Dexamethasone Suppression Test for melancholia.
        Br J Psychiatry. 1982; 140: 292
        • Carroll BJ
        Clinical application of the Dexamethasone Suppression Test for endogenous depression.
        Pharmacopsychiatry. 1982; 15: 19
        • Carroll BJ
        • Mendels J
        Neuroendocrine regulation in affective disorders.
        in: Sachar EJ Hormones Behavior and Psychopathology. Raven Press, New York1976: 193-224
        • Carroll BJ
        • Martin FIR
        • Davies BM
        The resistance to suppression by dexamethasone of plasma 11-OHCS levels in severe depressive illnesses.
        Br Med J. 1968; 3: 285
        • Carroll BJ
        • Curtis GC
        • Mendels J
        Neuroendocrine regulation in depression. I. Adrenocortical dysfunction.
        Arch Gen Psychiatry. 1976; 33: 1039
        • Carroll BJ
        • Feinberg M
        • Greden JF
        • Tarika J
        • Albala AA
        • Haskett RF
        • James McI
        • Kronfol Z
        • Lohr N
        • Steiner M
        • de Vigne JP
        • Young E
        A specific laboratory test for the diagnosis of melancholia; Standardization, validation, and clinical utility.
        Arch Gen Psychiatry. 1981; 38: 15
        • Della Corte L
        • Broadhurst AD
        • Sgragli GP
        • Fillippini S
        • Helley AF
        • James HD
        • Faravelli G
        • Pazzagli A
        Clinical response and tricyclic plasma levels during treatment with clomipramine.
        Br J Psychiatry. 1979; 134: 390
        • Extein I
        • Pottash ALC
        • Gold MS
        Relationship of thyrotropin-releasing hormone test and Dexamethasone Suppression Test abnormalities in unipolar depression.
        Psychiatr Res. 1981; 4: 49
        • Extein I
        • Pottash ALC
        • Gold MS
        • Cowdy RW
        Changes in TSH response to TRH in affective illness.
        in: Post RM Ballenger JC Neurobiology of Mood Disorders. Williams & Wilkins, Baltimore1984: 297-310
        • Fraser AR
        Choice of antidepressant based on the Dexamethasone Suppression Test.
        Am J Psychiatry. 1983; 140: 786
        • Fuwano S
        • Matsui N
        • Miyashita O
        • Sakai M
        • Yaginuma H
        • Togashi S
        • Wachi M
        • Okuda M
        • Itoh N
        Decreased level of plasma TRH-like immunoreactivity and abnormalities of DST, TRH test in depressed patients.
        in: Abstracts of the XVth International Society of Psychoneuroendocrinology, Kyoto, Japan1985
        • Fuwano S
        • Matsui N
        • Miyashita O
        • Sakai M
        • Yaginuma H
        • Togashi S
        • Wachi M
        • Okuda M
        • Itoh N
        Decreased plasma TRH-like immunoreactivity in depressed patients. IInd report—Radioimmunoassay for measuring plasma TRH-like immunoreactivity and its clinical application.
        Jpn J Neuropsychopharmacol. 1985; 9: 615
        • Gibbon JL
        Cortisol secretion rates in depressive illness.
        Arch Gen Psychiatry. 1964; 10: 572
        • Gold PW
        • Goodwin FK
        • Wehr T
        • Rebar R
        Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: Relationship to spinal fluid amine metabolites.
        Am J Psychiatry. 1977; 134: 1028
        • Goodwin FR
        • Rubovits R
        • Jimerson D
        • Post RM
        Serotonin and norepinephrine “subgroups” in depression.
        in: Scientific Proceedings of the American Psychiatric Association, Washington, DC American Psychiatric Association, 1977: 108
        • Grimm Y
        • Reichlin S
        Thyrotropin-releasing hormone (TRH): Neurotransmitter regulation of secretion by mouse hypothalamic tissue in vitro.
        Endocrinology. 1973; 93: 626
        • Hamilton M
        Development of a rating scale for primary depressive illness.
        Br J Soc Clin Psychol. 1967; 6: 278
        • Hökfelt T
        • Jahansson O
        • Ljungdahl A
        • Lundberg JM
        • Schultzberg M
        Peptidergic neurones.
        Nature. 1980; 284: 515
        • Hunter WM
        • Greenwood FC
        Preparation of iodine 131 labelled human growth hormone of high specific activity.
        Nature. 1962; 194: 495
        • Jackson IMD
        Hypothalamic releasing hormones: Mechanisms underlying neuroendocrine dysfunction in affective disorders.
        in: Brown GM Koslow SH Reichlin S Neuroendocrinology and Psychiatric Disorder. Raven Press, New York1984: 255-266
        • Joffe R
        • Brown P
        • Bienerstock A
        • Mitton J
        Neuroendocrine predictors for the antidepressant effect of partial sleep deprivation.
        Biol Psychiatry. 1984; 19: 347
        • Kastin AJ
        • Ehrensing RH
        • Schalch DS
        • Anderson MS
        Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin releasing hormone.
        Lancet. 1972; ii: 740
        • Kirkegaard C
        The thyrotropin response to thyrotropin releasing hormone in endogenous depression.
        Psychoneuroendocrinology. 1981; 6: 189
        • Kirkegaard C
        • Carroll BJ
        Dissociation of TSH and adrenocortical disturbances in endogenous depression.
        Psychiatry Res. 1980; 3: 253
        • Kirkegaard C
        • Nørlem N
        • Lauridsen UB
        • Bjørum N
        Prognostic value of thyrotropin-releasing hormone stimulation test in endogenous depression.
        Acta Psychiatr Scand. 1975; 52: 170
        • Kirkegaard C
        • Bjørum N
        • Cohn D
        • Aaber J
        • Lauridsen UB
        • Nerup J
        Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depression.
        Psychoneuroendocrinology. 1977; 2: 131
        • Kirkegaard C
        • Faber J
        • Hummer L
        • Rogowski P
        Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression.
        Psychoneuroendocrinology. 1979; 4: 227
        • Krog-Meyer I
        • Kirkegaard C
        • Kijne B
        • Lumholtz B
        • Smith E
        • Lykke-Olesen L
        • Bjørum N
        Effect of amitriptyline on the thyrotropin response to thyrotropin-releasing hormone in endogenous depression.
        Psychiatry Res. 1984; 15: 145
        • Krog-Meyer I
        • Kirkegaard C
        • Kijne B
        • Lumholtz B
        • Smith E
        • Lykke-Olesen L
        • Bjørum N
        Prediction of relapse with the TRH test and prophylactic amitriptyline in 39 patients with endogenous depression.
        Am J Psychiatry. 1984; 141: 945
        • Langer G
        • Schonbeck G
        • Koinig G
        • Lesch O
        • Schussler M
        • Waldhusl W
        Antidepressant drugs and the hypothalamic-pituitary-thyroid axis.
        Lancet. 1980; i: 100
        • Langer G
        • Karobath M
        • Sieghart W
        • Aschaner H
        • Placheta P
        • Spona J
        Effects of antide-pressant treatment with clomipramine on hormonal responses to thyrotropin-releasing hormone and insulin-induced hypoglycemia: Implication for the “monoamine-hypothesis.”.
        Pharmacopsychiatry. 1981; 14: 100
        • Loosen PT
        The TRH-induced TSH response in psychiatric patients: A possible neuroendocrine marker.
        Psychoneuroendocrinology. 1985; 10: 237
        • Loosen PT
        • Prange AJ
        Serum thyrotropin response to thyrotropin releasing hormone in psychiatric patients: A review.
        Am J Psychiatry. 1982; 139: 405
        • Loosen PT
        • Kistler K
        • Prange Jr, AJ
        The use of the TRH-induced TSH response as an independent variable.
        Am J Psychiatry. 1983; 140: 700
        • Loosen PT
        • Wilson IC
        • Dew BW
        • Tipermas A
        TRH in abstinent alcoholic men.
        Am J Psychiatry. 1983; 130: 1145
        • Loosen PT
        • Youngblood W
        • Dew B
        Plasma levels of exogenous TRH in normal subjects and two patients with TSH blunting.
        Psychopharmacol Bull. 1983; 19: 325
        • Maeda K
        • Kato Y
        • Ohgo S
        • Chihara K
        • Yoshimoto Y
        • Yamaguchi N
        • Kuromaru S
        • Imura H
        Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression.
        J Clin Endocrinol Metab. 1975; 40: 501
        • Nemeroff CB
        • Bissette G
        • Manberg PJ
        Neurotensin-induced hypothermia; evidence for an interaction with dopaminergic systems and the hypothalamic-pituitary-thyroid axis.
        Brain Res. 1980; 195: 68
        • Nelson WH
        • Orr WW
        • Stevenson JM
        • Shane R
        Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
        Arch Gen Psychiatry. 1981; 39: 1033
        • Nicoloff CB
        • Fisher DA
        • Appleman MD
        The role of glucocorticoids in the regulation of thyroid function in man.
        J Clin Invest. 1979; 49: 1922
        • Nordren L
        • Scheele C
        Nortriptyline and pituitary-thyroid function in affective disorders.
        Pharmacopsychiatry. 1981; 14: 61
        • Otsuki M
        • Dakoda M
        • Baba S
        Influence of glucocorticoids on TRH induced TSH response in man.
        J Clin Endocrinol Metab. 1973; 36: 95
        • Papakostas Y
        • Fink M
        • Lee J
        • Irwin P
        • Johnson L
        Neuroendocrine measures in psychiatric patients: Course and outcome with ECT.
        Psychiatry Res. 1981; 4: 55
        • Prange AJ
        • Wilson IC
        • Lara PP
        • Alltop LB
        Effects of thyrotropin releasing hormone in depression.
        Lancet. 1972; ii: 999
        • Ramey JN
        • Burrow GN
        • Spaulding SW
        • Donabedian RK
        • Speroff L
        • Frantz AG
        The effects of aspirin and indomethacin on the TRH response in man.
        J Clin Endocrinol Metab. 1976; 43: 107
        • Re RB
        • Kourides IA
        • Ridgeway EC
        • Weintraub BD
        • Maloof F
        The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin.
        J Clin Endocrinol Metab. 1976; 43: 338
        • Reichlin S
        • Jackson IMD
        • Seyler LE
        • Grimm Y
        Regulation of the secretion TRH and LHRH.
        in: Seeman P Brown GM Frontiers in Neurology and Neuroscience Research. University of Toronto Press, Toronto1974: 48-59
        • Rubin RT
        • Marker SR
        Biological markers in affective and schizophrenic disorders: A review of contemporary research.
        in: Zales MR Affective and Schizophrenic Disorders: New Approaches to Diagnosis and Treatment. Brunner, New York1983: 53-73
        • Rubinow DR
        • Post RM
        • Gold PW
        • Ballenger JC
        • Wolff EA
        The relationship between cortisol and clinical phenomenology of affective illness.
        in: Post RM Ballenger JC Neurobiology of Mood Disorders. Williams & Wilkins, Baltimore1983: 271-287
        • Sachar EJ
        Psychiatric disturbances associated with endocrine disorders.
        in: American Handbook of Psychiatry. vol. 4. Basic Books, New York1975: 229-313
        • Sachar EJ
        • Hellman L
        • Roffwarg HP
        • Halperu FS
        • Fukushima DK
        • Gallagher TF
        Disrupted 24-hour patterns of cortisol secretion in psychotic depression.
        Arch Gen Psychiatry. 1973; 28: 19
        • Saito S
        • Musa K
        • Yamamoto S
        • Oshima I
        • Funato T
        Radioimmunoassay of thyrotropin releasing hormone in plasma and urine.
        Endocrinol Jpn. 1975; 22: 303
        • Scanlon MF
        • Weightman Dr
        • Shale DJ
        • Mora B
        • Heath M
        • Show MH
        • Lewis M
        • Hall R
        Dopamine is a physiological regulator of thyrotropin (TSH) secretion in normal man.
        Clin Endocrinol. 1979; 10: 7
        • Sternbach HA
        • Kirstein L
        • Pottash ALC
        • Gold MS
        • Extein I
        • Sweeny Dr
        The TRH test and urinary MHPC in unipolar depression.
        J Affect Dis. 1983; 5: 233
        • Sternbach HA
        • Gwirtsman HE
        • Genor RH
        Biological tests in the diagnosis and treatment of affective disorders.
        in: Shah NS Donald AG Psychoneuroendocrine Dysfunction. Plenum, New York1984: 383-398
        • Targum SD
        The application of serial neuroendocrine challenge studies in management of depressive disorders.
        Biol Psychiatry. 1983; 18: 3
        • Targum SD
        Persistent neuroendocrine dysregulation in major depressive disorder: A marker for early relapse.
        Biol Psychiatry. 1984; 19: 305
        • Targum SD
        • Sullivan AC
        • Byrnes SM
        Neuroendocrine interrelationships in major depressive disorders.
        Am J Psychiatry. 1982; 139: 282
        • Widerlöv E
        • Wide L
        • Sjöström R
        Effects of tricyclic antidepressants on human plasma levels of TSH, GH and prolactin.
        Acta Psychiatr Scand. 1978; 58: 449
        • Willer JF
        • Utiger RD
        The effect of glucocorticoids on the thyrotropin secretion.
        J Clin Invest. 1969; 48: 2096